Skip to content

Alliqua Biomedical Inc股票

Alliqua Biomedical Inc股票

Adynxx Inc., formerly Alliqua BioMedical, Inc., is a clinical stage biopharmaceutical company. The Company is focused on development of non-opioid therapeutics for the treatment of pain and inflammatory diseases. Its AYX platform utilizes a proprietary technology of non-opioid, disease-modifying transcription factor decoys. Alliqua, Inc., (OTCBB:ALQA) is a biomedical company focused on the development, manufacturing and marketing of its own proprietary products, utilizing its existing technology portfolio. The company currently markets its own proprietary brands of wound dressings: SilverSeal® Hydrogel, an antimicrobial dressing; and Hydress® a moist wound dressing. 1 Alliqua BioMedical Inc (ALQA) Stock Monthly Growth. Below graph shows the monthly growth of Alliqua BioMedical Inc (ALQA) in percentage units. The height of the bars will give you a fair idea of the magnitude of growth for the respective months. Below table contains the data used to create the above graph for Alliqua BioMedical Inc (ALQA). Alliqua BioMedical, Inc.(NASDAQ:ALQA)创立于1997年,总部位于美国宾州Yardley,全职雇员60人,是一家再生技术公司,商业化再生医疗产品,帮助身体修复或更换软组织。 Alliqua BioMedical, Inc.(ALQA)美股百科: Alliqua

ALLIQUA BIOMEDICAL INC. - 图表 和 历史数据

Alliqua, Inc. is a biomedical company. The company focused on the development, manufacturing and distribution of proprietary transdermal wound care and drug delivery technologies. Its technology platform produces hydrogels, a 3-dimensional cross-linked network of water soluble polymers. Alliqua BioMedical Inc - ALQA - Stock forecast - 3 months ... Adynxx Inc., formerly Alliqua BioMedical, Inc., is a clinical stage biopharmaceutical company. The Company is focused on development of non-opioid therapeutics for the treatment of pain and Celularity, Inc., Accelerates Breakthrough Placental Discovery and Therapeutic Platform ALQA Institutional Ownership - Alliqua, Inc. Stock

YARDLEY, Pa., March 29, 2017 -- Alliqua BioMedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"), a regenerative technologies company committed to restoring tissue and rebuilding lives, today

Levered/Unlevered Beta of Alliqua BioMedical Inc. ( ALQA | USA) Beta is a statistical measure that compares the volatility of a stock against the volatility of the broader market, which is typically measured by a reference market index. Since the market is the benchmark, the market's beta is always 1. Get directions, reviews and information for Alliqua BioMedical Inc in Eden Prairie, MN. Alliqua BioMedical Inc 11495 Valley View Rd Eden Prairie MN 55344. Reviews (952) 224-8700 Website. Menu & Reservations Make Reservations . Order Online Tickets Tickets See Availability

Alliqua Biomedical Inc. Archives - Stock News Union

Alliqua BioMedical - Stock Price History | ADYX | MacroTrends Historical daily share price chart and data for Alliqua BioMedical since 2020 adjusted for splits. The latest closing stock price for Alliqua BioMedical as of June 12, 2019 is 3.61.. The all-time high Alliqua BioMedical stock closing price was 8.91 on May 06, 2019.; The Alliqua BioMedical 52-week high stock price is 6.07, which is 68.1% above the current share price. Alliqua Company Profile - Office Locations, Competitors ...

LANGHORNE, Pa. and SAN FRANCISCO, Oct. 12, 2018 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (Nasdaq:ALQA) and Adynxx, Inc., a privately held biopharmaceutical company, today announced that they have entered into a definitive merger agreement under which the stockholders of Adynxx would become the majority owners of Alliqua's outstanding common stock on a fully-diluted basis.

Alliqua, Inc., (OTCBB:ALQA) is a biomedical company focused on the development, manufacturing and marketing of its own proprietary products, utilizing its  A high-level overview of Adynxx, Inc. (ADYX) stock. Stay up to date on the latest Alliqua BioMedical Raises Outlook, Remains Attractively Valued. Wed, Feb. 5 Stocks Under $10 Set to Soar · By Roberto Pedone. Apr 30, 2015 9:34 AM EDT. Alliqua Roll Continues With Nasdaq Listing. VIDEO  22 Dec 2010 The name change will have no effect on voting and other rights accompanying the Company's common stock, and the Company will retain its  2 Feb 2015 The merger agreement provides for additional contingent payments in stock and cash, under certain circumstances, if stated revenue thresholds  2010-2020 Macrotrends LLC | Terms of Service | Privacy Policy | Contact Us Fundamental data from Zacks Investment Research, Inc. 12 Oct 2018 PRNewswire/ -- Alliqua BioMedical, Inc. (Nasdaq:ALQA) and Adynxx, shares of the Alliqua common stock issued and outstanding following 

Apex Business WordPress Theme | Designed by Crafthemes